Results 21 to 30 of about 7,203,866 (304)

Symposium: New horizons in the treatment of type 1 diabetes mellitus. New insulins. Smart insulin

Revista de la Sociedad Argentina de Diabetes, 2021
In 1921, Dr. Banting's impressive intuition led to discovery and subsequent crystallization of insulin in Toronto University. Its administration to the patient Leonard Thompson marked a historic milestone in humanity and immediately determined a ...
Guillermo Dieuzeide
doaj   +1 more source

Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease [PDF]

, 2011
Background Long-acting beta2-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However,
David J Evans, Spencer, Sally, Spencer, S, Evans, David, Karner, C, Cates, CJ, Charlotta Karner, Christopher J Cates, Sally Spencer, Karner, Charlotta, Evans, DJ, Cates, Christopher, Spencer, Sally; id_orcid   +12 more
core   +1 more source

Assessment of the use of long-acting insulin in management of diabetic ketoacidosis in pediatric patients: a randomized controlled trial [PDF]

Annals of Pediatric Endocrinology & Metabolism
Purpose We evaluated the effectiveness of early start of long-acting insulin during management of diabetic ketoacidosis (DKA) in pediatric patients. Methods Patients with DKA were randomly assigned to receive either a traditional DKA management protocol ...
Amany El Hawary, Ali Sobh, Ashraf Elsharkawy, Gad Gamal, Mohammad Hosny Awad   +4 more
doaj   +1 more source

Long-acting beta2-agonists for chronic obstructive pulmonary disease. [PDF]

, 2013
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up.
Walters, JA, Chris Mavergames, Kew, KM, Mavergames, C, Kayleigh M Kew, Julia AE Walters   +5 more
core   +1 more source

Maternal and neonatal outcomes with the use of long acting, compared to intermediate acting basal insulin (NPH) for managing diabetes during pregnancy: a systematic review and meta-analysis

Diabetology & Metabolic Syndrome, 2022
Background To assess the impact of long-acting insulin analogues, compared to intermediate acting neutral protamine Hagedron (NPH), on maternal, perinatal and neonatal outcomes.
Jijiao Wang, Xiaochen Ji, Ting Liu, Nan Zhao   +3 more
doaj   +1 more source

A population-based analysis of insulin management patterns in a province of southern Spain (2014-2018)

Spanish Journal of Medicine, 2022
Aim: The aim of this study was to analyze the patterns of insulin consumption between 2014 and 2018 in Cádiz. Methods: This study was a cross-sectional retrospective study. All people that used any insulin were included in the study.
José Escribano-Serrano, Enrique Jiménez-Varo, María-Isabel Méndez-Esteban, Antonio García-Bonilla, Manuela Márquez-Ferrando, Antonio Hormigo-Pozo, José Mancera-Romero, Alfredo Michán-Doña   +7 more
doaj   +1 more source

Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital [PDF]

Diabetes & Metabolism Journal, 2022
Background Prevailing insulin regimens for glycemic control in hospitalized patients have changed over time. We aimed to determine whether the current basal-bolus insulin (BBI) regimen is superior to the previous insulin regimen, mainly comprising split ...
Sun Joon Moon, Hun Jee Choe, Soo Heon Kwak, Hye Seung Jung, Kyong Soo Park, Young Min Cho   +5 more
doaj   +1 more source

Analysis of the quality of life of patients with type 1 diabetes mellitus in real clinical practice who received insulin degludec

Медицинский совет, 2021
Introduction. Long-term and high-quality glycemic control prevents the development of vascular complications of diabetes type 1 and improves the disease prognosis, significantly increasing life expectancy.
L. A. Suplotova, A. S. Sudnitsyna, N. V. Romanova   +2 more
doaj   +1 more source

Drug review - insulin glargine: a long acting insulin analog

, 2005
The main goal of treatment of diabetes mellitus (DM) is to maintain long term near normoglycemia. Insulin therapy plays a pivotal role in the management of DM.
P. N. Chakkarwar, N. A. Manjreka
core   +3 more sources

Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes

Therapeutic Advances in Endocrinology and Metabolism, 2012
The three currently marketed long-acting insulin analogs, glargine, detemir and insulin lispro protamine suspension (ILPS), represent the most significant advances in basal insulin supplementation since the 1940s and 1950s and the introduction of the ...
Dario Giugliano, Katherine Esposito
doaj   +1 more source